Torrent Pharma surges on entering into exclusive licensing agreement with Reliance Life Sciences

29 Dec 2014 Evaluate

Torrent Pharmaceuticals is currently trading at Rs. 1096.00, up by 11.10 points or 1.02% from its previous closing of Rs. 1084.90 on the BSE.

The scrip opened at Rs. 1090.00 and has touched a high and low of Rs. 1106.00 and Rs. 1085.00 respectively. So far 4855 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1188.00 on 03-Dec-2014 and a 52 week low of Rs. 461.40 on 03-Jan-2014.

Last one week high and low of the scrip stood at Rs. 1110.00 and Rs. 1029.90 respectively. The current market cap of the company is Rs. 18541.73 crore.

The promoters holding in the company stood at 71.51% while Institutions and Non-Institutions held 19.37% and 9.12% respectively.

Torrent Pharmaceuticals has entered into an exclusive licensing agreement with Reliance Life Sciences for marketing 3 biosimilars in India - Rituximab, Adalimumab and Cetuximab. As per the agreement, Reliance Life Sciences will develop and supply these products to Torrent Pharma after obtaining all necessary regulatory approvals. Torrent Pharma will be the only company to market these biosimilars in India other than Reliance Life Sciences. Reliance Life Sciences will manufacture these products at its facility in Navi Mumbai and supply to Torrent Pharma for a period of ten years.

Torrent Pharma forayed into the oncology and dermatology segments in 2011-12 with the launch of exclusive divisions and has since gained a strong position in these segments. The licensing agreement with Reliance Life Sciences is expected to significantly boost its presence in these segments in the coming years.

Rituximab and Cetuximab cater to the oncology segment and are used in the treatment of various cancers like leukemia, lymphoma, colorectal, head and neck cancers. Adalimumab is the most preferred therapy for the treatment of auto immune disorders like rheumatoid arthritis, psoriasis and IBD.

Torrent Pharma Share Price

2641.10 -47.10 (-1.75%)
30-Apr-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1502.30
Dr. Reddys Lab 6198.90
Cipla 1402.20
Zydus Lifesciences 957.00
Lupin 1645.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.